Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market
NetworkNewsWire Editorial Coverage: Artificial intelligence (“AI”) continues to transform healthcare innovation, with medical imaging emerging as one of its most promising frontiers. In breast cancer detection, where early identification often determines patient outcomes, AI-powered imaging technologies are pushing beyond the technical constraints of traditional mammography, tomosynthesis, and MRI. Globally, breast cancer remains the most frequently diagnosed cancer among women. The World Health Organization (“WHO”) reported that more than 2.3 million women were diagnosed, with approximately 670,000 losing their lives to the disease in 2022. In the United States, the American Cancer Society (“ACS”) estimates that 316,950 new invasive breast cancer cases will be identified this year alone. This…







